Medindia

X

VEGF Trap-Eye Shows Positive Results in a Phase 2 Study in Patients With Diabetic Macular Edema

Thursday, February 18, 2010 Research News J E 4
Advertisement
- Statistically significant improvement in vision achieved over 24 weeks

Contact Information:

Regeneron Pharmaceuticals, Inc.

Peter Dworkin

Laura Lindsay

Investor Relations

Media Relations

914.345.7640

914.345.7800

peter.dworkin@regeneron.com

laura.lindsay@regeneron.com

Bayer HealthCare

Anna Koch,

+49 30 468-15942

anna.koch@bayerhealthcare.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
West Announces Fourth Quarter, Full Year 2009 Resu...
S
Gentiva(R) Health Services Reports Fourth Quarter ...